Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC31934NFAT Transcription Factor RegulatorCAS: 245747-71-1纯度: >99.00%
NFAT Transcription Factor Regulator 是一种 IL-2 合成抑制剂,IC50 为 182 nM。
- GC32038PGS-IN-1 (KME-4)CAS: 102271-49-8纯度: >99.50%
PGS-IN-1 (KME-4) 是一种有效的前列腺素合成酶 (PGS) 抑制剂,IC50 为 0.28 μM;也抑制 5-脂氧合酶,IC50 为 1.05 μM.
- GC32186Puromycin (CL13900)CAS: 53-79-2纯度: {{1-12}>98.00%}
Puromycin 2HCl (CL13900) is an aminonucleoside antibiotic, which acts as a protein synthesis inhibitor.
- GC32439Ferulic acid sodium (Sodium ferulate)CAS: 24276-84-4纯度: >99.00%
A phenol with diverse biological activities
- GC32681GSK2795039CAS: 1415925-18-6纯度: >99.50% / >98.00%
GSK2795039是一种强效NADPH氧化酶2(NOX2)抑制剂,IC 50 值为0.18μM。
- GC32705(-)-DHMEQ (Dehydroxymethylepoxyquinomicin)CAS: 287194-40-5纯度: >98.50%
(-)-DHMEQ (Dehydroxymethylepoxyquinomicin) (Dehydroxymethylepoxyquinomicin) 是一种有效、选择性和不可逆的 NF-κB 抑制剂,可与半胱氨酸残基共价结合。
- GC32723CDDO-Im (RTA-403)CAS: 443104-02-7纯度: >98.00%
CDDO-Im (RTA-403)是一种合成三萜类化合物,通过与Kelch样ECH相关蛋白1(Keap1)结合抑制核因子E2相关因子(Nrf2)的降解,从而激活Nrf2信号通路并提高其蛋白水平。
- GC32737TAK-243 (MLN7243)CAS: 1450833-55-2纯度: >98.00%
TAK-243 (MLN7243)是一种选择性泛素活化酶(UBA1)抑制剂,IC 50 值为1nM。
- GC32762Icaritin (Anhydroicaritin)CAS: 118525-40-9纯度: >99.00%
Icaritin (Anhydroicaritin)是从中药淫羊藿中提取的天然黄酮类化合物。Icaritin (Anhydroicaritin)常用于抗癌、骨骼保护、抗炎、神经保护、心血管保护和抗病毒等领域的研究。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC31934 | NFAT Transcription Factor Regulator | 245747-71-1 | >99.00% | |
NFAT Transcription Factor Regulator 是一种 IL-2 合成抑制剂,IC50 为 182 nM。 | ||||
| GC31948 | IX 207-887 | 98320-39-9 | - | |
IX207-887是一种新型抗关节炎药物,也能抑制白细胞介素-1(IL-1)的释放。 | ||||
| GC32019 | Interferon receptor agonist | 2215120-36-6 | >99.50% | |
干扰素受体激动剂(化合物 6)是一种干扰素 (IFN) 受体诱导剂。 | ||||
| GC32028 | BMS-066 | 914946-88-6 | - | |
BMS-066是IKKβ/Tyk2的抑制剂,其IC50值分别为9nM,72nM。 | ||||
| GC32038 | PGS-IN-1 (KME-4) | 102271-49-8 | >99.50% | |
PGS-IN-1 (KME-4) 是一种有效的前列腺素合成酶 (PGS) 抑制剂,IC50 为 0.28 μM;也抑制 5-脂氧合酶,IC50 为 1.05 μM. | ||||
| GC32041 | Triphala | 857906-76-4 | - | |
Triphala是阿育吠陀的多草药配方,Triphala由三种草本植物Terminaliachebula,Terminaliabellerica,和Phyllanthusemblica组成。Triphala抑制NF-κB活化。Triphala发挥抗真菌(antifungal)作用。具有抗脂肪形成,抗炎,抗肿瘤效果。 | ||||
| GC32057 | AN-3485 | 1213827-99-6 | >98.50% | |
AN-3485是一种benzoxaborole类似物,Toll样受体Toll-LikeReceptors(TLRs)抑制剂,IC50范围为18~580nM。 | ||||
| GC32170 | Methyl gallate (Gallincin) | 99-24-1 | >99.50% | |
A phenol with diverse biological activities | ||||
| GC32186 | Puromycin (CL13900) | 53-79-2 | {{1-12}>98.00%} | |
Puromycin 2HCl (CL13900) is an aminonucleoside antibiotic, which acts as a protein synthesis inhibitor. | ||||
| GC32216 | Squalene (Super Squalene) | 111-02-4 | >98.00% | |
A biosynthetic precursor to steroids | ||||
| GC32439 | Ferulic acid sodium (Sodium ferulate) | 24276-84-4 | >99.00% | |
A phenol with diverse biological activities | ||||
| GC32457 | Asymmetric dimethylarginine | 30315-93-6 | >98.00% | |
An endogenous NOS inhibitor | ||||
| GC32486 | AVE-3085 | 450348-85-3 | >99.50% | |
AVE-3085是一种有效的nitricoxidesynthase增强剂,常用于治疗心血管疾病。 | ||||
| GC32681 | GSK2795039 | 1415925-18-6 | >99.50% / >98.00% | |
GSK2795039是一种强效NADPH氧化酶2(NOX2)抑制剂,IC 50 值为0.18μM。 | ||||
| GC32705 | (-)-DHMEQ (Dehydroxymethylepoxyquinomicin) | 287194-40-5 | >98.50% | |
(-)-DHMEQ (Dehydroxymethylepoxyquinomicin) (Dehydroxymethylepoxyquinomicin) 是一种有效、选择性和不可逆的 NF-κB 抑制剂,可与半胱氨酸残基共价结合。 | ||||
| GC32723 | CDDO-Im (RTA-403) | 443104-02-7 | >98.00% | |
CDDO-Im (RTA-403)是一种合成三萜类化合物,通过与Kelch样ECH相关蛋白1(Keap1)结合抑制核因子E2相关因子(Nrf2)的降解,从而激活Nrf2信号通路并提高其蛋白水平。 | ||||
| GC32737 | TAK-243 (MLN7243) | 1450833-55-2 | >98.00% | |
TAK-243 (MLN7243)是一种选择性泛素活化酶(UBA1)抑制剂,IC 50 值为1nM。 | ||||
| GC32762 | Icaritin (Anhydroicaritin) | 118525-40-9 | >99.00% | |
Icaritin (Anhydroicaritin)是从中药淫羊藿中提取的天然黄酮类化合物。Icaritin (Anhydroicaritin)常用于抗癌、骨骼保护、抗炎、神经保护、心血管保护和抗病毒等领域的研究。 | ||||
| GC32795 | PSB-12379 | 1802226-78-3 | >99.50% | |
An inhibitor of CD73 | ||||
| GC32887 | Efaproxiral (RSR13) | 131179-95-8 | >99.50% | |
An allosteric hemoglobin modifier | ||||
| GC32946 | PK11007 | 38275-34-2 | >99.00% | |
PK11000 stabilizes the DBD of both WT and mutant p53 proteins by covalent cysteine modification without compromising DNA binding and effective in inducing cell death. | ||||
| GC32965 | Ethoxyquin | 91-53-2 | >98.00% | |
An antioxidant used in animal feed | ||||
| GC32999 | Glucoraphanin | 21414-41-5 | >98.00% | |
A natural compound with protective effects | ||||
| GC33070 | ARN-3236 | 1613710-01-2 | >99.50% | |
ARN-3236是一种选择性盐诱导激酶2(SIK2)抑制剂(IC 50 <1nM)。ARN-3236也可抑制SIK1(IC 50 <21.63nM)和SIK3(IC 50 <6.63nM)的活性。 | ||||
